NIOX logo

NIOX Group Plc Stock Price

AIM:NIOX Community·UK£300.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

NIOX Share Price Performance

UK£0.72
0.07 (10.12%)
UK£0.72
0.07 (10.12%)
Price UK£0.72

NIOX Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
2 Rewards

NIOX Group Plc Key Details

UK£46.0m

Revenue

UK£13.3m

Cost of Revenue

UK£32.7m

Gross Profit

UK£27.8m

Other Expenses

UK£4.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.012
71.09%
10.65%
0%
View Full Analysis

About NIOX

Founded
2006
Employees
91
CEO
Jonathan Emms
WebsiteView website
www.niox.com

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Recent NIOX News & Updates

Recent updates

No updates